PARTNERSHIPS

The current portfolio of developed nutraceutical products include:

1. SP003P – a proprietary concentrated plant extract from Euphorbia hirta for the treatment of asthma.
2. SP002P – a proprietary highly refined standardized fraction from Wax myrtle.

PhytoPharmacon has used proprietary technologies to prepare these products with defined components that result in the inhibition of multiple disease specific pathways and provide definite advantage over traditional pharmaceuticals.

<< Back